# EDGAR Filing Document

**Accession Number:** 0000933974
**File Stem:** 0001437749-25-037345
**Filing Date:** 2025-12
**Character Count:** 13485
**Document Hash:** 7167274448c3791bf01254f524d81be4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-037345.hdr.sgml**: 20251210

**ACCESSION NUMBER**: 0001437749-25-037345

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 78

**CONFORMED PERIOD OF REPORT**: 20251209

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251210

**DATE AS OF CHANGE**: 20251210

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Azenta, Inc.
- **CENTRAL INDEX KEY:** 0000933974
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIAL INDUSTRY MACHINERY, NEC [3559]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 043040660
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-25434
- **FILM NUMBER:** 251561390

**BUSINESS ADDRESS:**
- **STREET 1:** 200 SUMMIT DRIVE
- **STREET 2:** 6TH FLOOR
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803
- **BUSINESS PHONE:** (978) 262-2400

**MAIL ADDRESS:**
- **STREET 1:** 200 SUMMIT DRIVE
- **STREET 2:** 6TH FLOOR
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Brooks Automation, Inc.
- **DATE OF NAME CHANGE:** 20190521

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BROOKS AUTOMATION INC
- **DATE OF NAME CHANGE:** 20030228

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BROOKS-PRI AUTOMATION INC
- **DATE OF NAME CHANGE:** 20020514

?xml version='1.0' encoding='ASCII'? azta20251209_8k.htm

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 or 15(d) OF** 

 **THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): December 9, 2025**

## Azenta, Inc.
(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **0-25434** | **04-3040660** |
| **(State or Other Jurisdiction**<br> **of Incorporation)** | **(Commission File**<br> **Number)** | **(IRS Employer**<br> **Identification No.)** |

---

**200 Summit Drive, 6<sup>th</sup> Floor, Burlington, MA 01803**

(Address of principal executive offices and Zip Code)

**(888) 229-3682**

(Registrant's telephone number, including area code)

**N/A**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.01 par value | AZTA | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 7.01. Regulation FD Disclosure.**

On December 10, 2025, Azenta, Inc. ("Azenta" or the "Company") issued a press release announcing the Repurchase Program (as defined below), a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In addition, as previously announced on October 15, 2025, Azenta will hold an Investor Day beginning at 1:00 p.m. ET on December 10, 2025. A copy of the presentation that will be used in connection with the Investor Day is attached hereto as Exhibit 99.2.

The information furnished in this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.

<u>Cautionary Note Regarding Forward-Looking Statements</u>. Except for historical information contained in the presentation attached as Exhibit 99.2 hereto, the presentation contains forward-looking statements which involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the presentation regarding these forward-looking statements.

**Item 8.01. Other Events.**

On December 8, 2025, the Board of Directors (the "Board") of Azenta authorized a stock repurchase program (the "Repurchase Program"), under which the Company may repurchase up to $250 million of its outstanding common stock. The Repurchase Program is intended to enhance shareholder value and capitalize on undervaluation. The Repurchase Program became effective on December 9, 2025 and is scheduled to expire on December 31, 2028, unless extended, suspended or terminated earlier by the Board.

Repurchases under the Repurchase Program may be made from time to time in the open market, in privately negotiated transactions, in accelerated share repurchases, through block trades, or through trading plans intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), in each case, subject to market conditions and applicable legal and regulatory requirements, including Rule 10b-18 under the Exchange Act. The timing, volume and price of repurchases will be determined at the discretion of the Company's management based on a variety of factors, including stock price, general business and market conditions, alternative investment opportunities, liquidity, and other considerations.

The Repurchase Program does not obligate the Company to acquire any particular amount of common stock, and it may be modified, suspended or terminated at any time without prior notice. Repurchases under the Repurchase Program are expected to be funded using the Company's available cash reserves, operating cash flow, or other sources as determined by management, consistent with the Company's financial policies.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| Exhibit No. | Description |

---

---

| | |
|:---|:---|
| 99.1 | [Press release dated December 10, 2025.](ex_897376.htm) |

---

---

| | |
|:---|:---|
| 99.2 | [Azenta, Inc. Investor Day Presentation dated December 10, 2025.](ex_897377.htm) |

---

---

| | |
|:---|:---|
| 104 | Cover Page Interactive Data File (embedded within Inline XBRL document). |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
|  | AZENTA, INC. |
|  | /s/ Ephraim Starr |
| Date: December 10, 2025 | Ephraim Starr |
|  | Senior Vice President, General Counsel and Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**

![logo.jpg](logo.jpg)

**Azenta Authorizes $250 Million Share Repurchase Program**

BURLINGTON, Mass., December 10, 2025 /PRNewswire/ --Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may repurchase up to $250 million of its outstanding common stock. The Repurchase Program is intended to enhance shareholder value and capitalize on undervaluation. Repurchases may be made from time to time through open market repurchases, privately negotiated transactions, or by other methods compliant with Rules 10b-18 and 10b5-1 of the Securities Exchange Act of 1934, subject to market and business conditions, applicable legal requirements, and other factors.

This authorization does not obligate Azenta to repurchase any specific dollar amount or number of shares, and repurchases may be commenced, suspended, modified, or discontinued at any time without prior notice. The Repurchase Program commenced on December 9, 2025, and continues until December 31, 2028, unless extended or terminated earlier by the Board.

"Our capital allocation strategy is grounded in four key levers — driving productivity and gross margin improvement, accelerating organic growth, pursuing strategic M&A with discipline, and returning capital to shareholders through share repurchases," said John Marotta, President and Chief Executive Officer. "The share repurchase authorization reflects our deliberate use of these levers to enhance long-term shareholder value while maintaining strategic flexibility to invest in growth."

**Forward-Looking Statements**

This press release contains forward-looking statements, including statements regarding the share repurchase program and its potential benefits. Forward-looking statements are based on management's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that could affect results include, among others, market conditions, business performance, stock price fluctuations, legal and regulatory requirements, and general economic conditions. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law.

------

**About Azenta Life Sciences**

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe, and Asia. For more information, please visit <u>www.azenta.com</u>.

INVESTOR CONTACTS:

Yvonne Perron

Vice President, Financial Planning & Analysis, and Investor Relations

<u>ir@azenta.com</u>

Maria Isabel Cuartas

Manager, Investor Relations

<u>ir@azenta.com</u>

## Exhibit 99.2

**Exhibit 99.2**

![slide01.jpg](slide01.jpg)

------

![slide02.jpg](slide02.jpg)

------

![slide03.jpg](slide03.jpg)

------

![slide04.jpg](slide04.jpg)

------

![slide05.jpg](slide05.jpg)

------

![slide06.jpg](slide06.jpg)

------

![slide07.jpg](slide07.jpg)

------

![slide08.jpg](slide08.jpg)

------

![slide09.jpg](slide09.jpg)

------

![slide10.jpg](slide10.jpg)

------

![slide11.jpg](slide11.jpg)

------

![slide12.jpg](slide12.jpg)

------

![slide13.jpg](slide13.jpg)

------

![slide14.jpg](slide14.jpg)

------

![slide15.jpg](slide15.jpg)

------

![slide16.jpg](slide16.jpg)

------

![slide17.jpg](slide17.jpg)

------

![slide18.jpg](slide18.jpg)

------

![slide19.jpg](slide19.jpg)

------

![slide20.jpg](slide20.jpg)

------

![slide21.jpg](slide21.jpg)

------

![slide22.jpg](slide22.jpg)

------

![slide23.jpg](slide23.jpg)

------

![slide24.jpg](slide24.jpg)

------

![slide25.jpg](slide25.jpg)

------

![slide26.jpg](slide26.jpg)

------

![slide27.jpg](slide27.jpg)

------

![slide28.jpg](slide28.jpg)

------

![slide29.jpg](slide29.jpg)

------

![slide30.jpg](slide30.jpg)

------

![slide31.jpg](slide31.jpg)

------

![slide32.jpg](slide32.jpg)

------

![slide33.jpg](slide33.jpg)

------

![slide34.jpg](slide34.jpg)

------

![slide35.jpg](slide35.jpg)

------

![slide36.jpg](slide36.jpg)

------

![slide37.jpg](slide37.jpg)

------

![slide38.jpg](slide38.jpg)

------

![slide39.jpg](slide39.jpg)

------

![slide40.jpg](slide40.jpg)

------

![slide41.jpg](slide41.jpg)

------

![slide42.jpg](slide42.jpg)

------

![slide43.jpg](slide43.jpg)

------

![slide44.jpg](slide44.jpg)

------

![slide45.jpg](slide45.jpg)

------

![slide46.jpg](slide46.jpg)

------

![slide47.jpg](slide47.jpg)

------

![slide48.jpg](slide48.jpg)

------

![slide49.jpg](slide49.jpg)

------

![slide50.jpg](slide50.jpg)

------

![slide51.jpg](slide51.jpg)

------

![slide52.jpg](slide52.jpg)

------

![slide53.jpg](slide53.jpg)

------

![slide54.jpg](slide54.jpg)

------

![slide55.jpg](slide55.jpg)

------

![slide56.jpg](slide56.jpg)

------

![slide57.jpg](slide57.jpg)

------

![slide58.jpg](slide58.jpg)

------

![slide59.jpg](slide59.jpg)

------

![slide60.jpg](slide60.jpg)

------

![slide61.jpg](slide61.jpg)

------

![slide62.jpg](slide62.jpg)